Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 1NETWORK 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Thoracic 2

Conditions

Leukemia 42Breast Neoplasms 32Carcinoma, Non-Small-Cell Lung 22Leukemia, Myeloid, Acute 21Lung Neoplasms 19Congenital Abnormalities 17Kidney Neoplasms 16Rectal Neoplasms 15Lymphoma 15Head and Neck Neoplasms 15Colorectal Neoplasms 15Squamous Cell Carcinoma of Head and Neck 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 14Melanoma 14Colonic Neoplasms 14Sarcoma 13Lymphoma, Follicular 11Carcinoma, Renal Cell 11Lymphoma, Large B-Cell, Diffuse 10Leukemia, Megakaryoblastic, Acute 10Prostatic Neoplasms 9Leukemia, Myelomonocytic, Acute 9Leukemia, Monocytic, Acute 9Leukemia, Erythroblastic, Acute 9Central Nervous System Neoplasms 9Multiple Myeloma 8Leukemia, Lymphocytic, Chronic, B-Cell 7Gliosarcoma 7Glioblastoma 7Esophageal Neoplasms 7

Interventions

Carboplatin 31Paclitaxel 26Radiotherapy 23Bevacizumab 19Erlotinib Hydrochloride 16Cisplatin 14Gemcitabine 12Gefitinib 11Docetaxel 11Taxes 9Pemetrexed 9Etoposide 5pegfilgrastim 4Radiotherapy, Conformal 4Radiation 4Neoadjuvant Therapy 4Chemotherapy, Adjuvant 4Cetuximab 4Vinorelbine 3Amplified Fragment Length Polymorphism Analysis 3Topotecan 2Thalidomide 2Sorafenib 2Radiosurgery 2Pharmacogenomic Testing 2Nivolumab 2Magnetic Resonance Spectroscopy 2Irinotecan 2Gene Expression Profiling 2Filgrastim 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Adenocarcinoma, Bronchiolo-Alveolar × Gene Expression Profiling × Clear all
NCT00550537 2017-06-08

Proteomic Profiling in Predicting Response in Patients Receiving Erlotinib for Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

Vanderbilt-Ingram Cancer Center

Phase 2 Completed
116 enrolled 11 charts
Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00900172 2017-05-19

Study of Blood and Tissue Samples From Patients With Locally Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer Treated With Bevacizumab, Carboplatin, and Paclitaxel

Eastern Cooperative Oncology Group

Completed
180 enrolled
Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡